Showing results (91-100 of 2,733) with videos related to

Sort By:
Pageof 274
Pharmacogenomics|August 5, 2022
Integrated in a systems pharmacology approach, pharmacogenetics holds the promise for personalized medicine in neonatesKarel Allegaert
Pharmacogenomics|April 29, 2020
Projected impact of pharmacogenomic testing on medications beyond antiplatelet therapy in percutaneous coronary intervention patientsRachel M Black, Alexis K Williams, Lindsay Ratner, et al.
Pharmacogenomics|April 15, 2020
Nimodipine-induced junctional bradycardia in an elderly patient with subarachnoid hemorrhageCourtney L James, Marion T Turnbull, William D Freeman
Pharmacogenomics|August 19, 2021
Molecular pathogenesis of hereditary lung cancer: a literature reviewSouraya Rammal, Hampig Raphael Kourie, Nadine Jalkh, et al.
Pharmacogenomics|August 19, 2021
Pharmacogenomics variants are associated with BMI differences between individuals with bipolar and other psychiatric disordersAggeliki Charalampidi, Zoe Kordou, Evangelia-Eirini Tsermpini, et al.
Pharmacogenomics|June 17, 2020
Functional genomics based on germline genome-wide association studies of endocrine therapy for breast cancerJacqueline Zayas, Sisi Qin, Jia Yu, et al.
Pharmacogenomics|April 18, 2020
Cost-effectiveness of combinatorial pharmacogenomic testing for depression from the Canadian public payer perspectiveJulie-Anne Tanner, Paige E Davies, Christopher C Overall, et al.
Pharmacogenomics|April 21, 2020
Pharmacoresponse in genetic generalized epilepsy: a genome-wide association studyStefan Wolking, Herbert Schulz, Anne T Nies, et al.
Pharmacogenomics|April 21, 2020
NUDT15 genetic variants are related to thiopurine-induced neutropenia in Thai children with acute lymphoblastic leukemiaApichaya Puangpetch, Rawiporn Tiyasirichokchai, Samart Pakakasama, et al.
Pharmacogenomics|April 21, 2020
Genetic variants associated with glycemic response to treatment with dipeptidylpeptidase 4 inhibitorsAnna Űrgeová, Martin Javorský, Lucia Klimčáková, et al.
Pageof 274